{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:01Z","timestamp":1761624721994,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2012R1A1A1005646"],"award-info":[{"award-number":["NRF-2012R1A1A1005646"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.dld.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T10:52:11Z","timestamp":1416221531000},"page":"114-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-7205","authenticated-orcid":false,"given":"Hyuk","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Noh","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Hoon","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Haeng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poong-Lyul","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.dld.2014.10.014_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1523-5378.2007.00575.x","article-title":"Helicobacter pylori gastritis, the unifying concept for gastric diseases","volume":"12","author":"Egan","year":"2007","journal-title":"Helicobacter"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2014.10.014_bib0010","first-page":"45","article-title":"The incidence of Helicobacter pylori infection","volume":"9","author":"Parsonnet","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.014_bib0015","first-page":"1480","article-title":"Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood","volume":"92","author":"Roosendaal","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2007.07.008","article-title":"Eradication therapy for Helicobacter pylori","volume":"133","author":"Vakil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0025","doi-asserted-by":"crossref","first-page":"f4587","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2014.10.014_bib0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2036.2011.04887.x","article-title":"Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough","volume":"34","author":"Gisbert","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.014_bib0035","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"Practice Parameters Committee of the American College of G. American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0040","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific consensus guidelines for Helicobacter pylori infection","volume":"24","author":"Fock","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.014_bib0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection \u2013 the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.014_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2009.00738.x","article-title":"Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition","volume":"15","author":"Asaka","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2014.10.014_bib0055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/jgh.12607","article-title":"Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition","volume":"29","author":"Kim","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.014_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1523-5378.2007.00468.x","article-title":"Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea","volume":"12","author":"Kim","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2014.10.014_bib0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3346\/jkms.2014.29.5.704","article-title":"Meta-analysis of first-line triple therapy for Helicobacter pylori eradication in Korea: is it time to change","volume":"29","author":"Gong","year":"2014","journal-title":"Journal of Korean Medical Science"},{"key":"10.1016\/j.dld.2014.10.014_bib0070","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De Francesco","year":"2010","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2014.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.014_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.014_bib0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","article-title":"Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment","volume":"148","author":"Jafri","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2014.10.014_bib0090","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/ajg.2009.555","article-title":"Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children","volume":"104","author":"Gatta","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.dld.2004.01.016","article-title":"Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?","volume":"36","author":"de Boer","year":"2004","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2014.10.014_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","article-title":"Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure","volume":"23","author":"Gisbert","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.014_bib0105","doi-asserted-by":"crossref","first-page":"e85620","DOI":"10.1371\/journal.pone.0085620","article-title":"Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials","volume":"9","author":"Peedikayil","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dld.2014.10.014_bib0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1572-0241.2006.00637.x","article-title":"Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis","volume":"101","author":"Saad","year":"2006","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jac\/47.4.459","article-title":"Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea","volume":"47","author":"Kim","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.dld.2014.10.014_bib0120","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/AAC.48.12.4843-4847.2004","article-title":"Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea","volume":"48","author":"Kim","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.dld.2014.10.014_bib0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/gut.2010.215350","article-title":"Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial","volume":"59","author":"Romano","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.014_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.dld.2012.08.025","article-title":"Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review","volume":"45","author":"Zullo","year":"2013","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2014.10.014_bib0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki334","article-title":"Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients","volume":"56","author":"Kim","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.dld.2014.10.014_bib0140","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/gut.2010.231233","article-title":"Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?","volume":"60","author":"Zullo","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2014.10.014_bib0145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5009\/gnl.2013.7.5.546","article-title":"Sequential therapy for Helicobacter pylori infection in Korea: systematic review and meta-analysis","volume":"7","author":"Kim","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2014.10.014_bib0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-230X-13-104","article-title":"Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4166\/kjg.2013.62.5.267","article-title":"Meta-analysis: sequential therapy is superior to conventional therapy for Helicobacter pylori infection in Korea","volume":"62","author":"Chung","year":"2013","journal-title":"Korean Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0160","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jgh.12397","article-title":"Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults","volume":"28","author":"Yoon","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2014.10.014_bib0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MCG.0b013e31820ac05e","article-title":"Understanding and appreciating sequential therapy for Helicobacter pylori eradication","volume":"45","author":"Graham","year":"2011","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0170","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1365-2036.2003.01592.x","article-title":"Review article: the treatment of refractory Helicobacter pylori infection","volume":"17","author":"Megraud","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.014_bib0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.3581","article-title":"Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication","volume":"23","author":"Ye","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.dld.2014.10.014_bib0180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1590\/1414-431X20132817","article-title":"The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials","volume":"46","author":"Zhang","year":"2013","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.dld.2014.10.014_bib0185","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2036.2010.04274.x","article-title":"Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication","volume":"31","author":"Molina-Infante","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2014.10.014_bib0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1523-5378.2012.00993.x","article-title":"Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China","volume":"17","author":"Qian","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2014.10.014_bib0195","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/hel.12056","article-title":"Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study","volume":"18","author":"Calhan","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2014.10.014_bib0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MCG.0b013e3181d04592","article-title":"Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea","volume":"44","author":"Hwang","year":"2010","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0205","first-page":"285","article-title":"Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication","volume":"51","author":"Jung","year":"2008","journal-title":"Korean Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0210","first-page":"19","article-title":"The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication","volume":"48","author":"Lee","year":"2006","journal-title":"Korean Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2014.10.014_bib0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.0083-8703.2006.00371.x","article-title":"Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection","volume":"11","author":"Cheon","year":"2006","journal-title":"Helicobacter"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865814007592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:08:26Z","timestamp":1761624506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865814007592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1590865814007592"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}